Patent ID: 8951976
Filing Date: 2015-02-10
Classification: A61K,A61P

Abstract:
1. A method for the inhibition of progression of a disease associated with abnormal accumulation of liver lipids wherein the disease associated with abnormal accumulation of liver lipids is selected form the group consisting of non-alcoholic fatty liver disease (NAFL), non-alcoholic steatohepatitis (NASH), hypernutritive fatty liver, alcoholic fatty liver disease, diabetic fatty liver and acute fatty liver of pregnancy, which comprises administering to a subject an effective amount of 2-(4-methoxybenzyl)phenyl β-D-glucopyranoside or 2-(4-methoxybenzyl)phenyl 6-O-ethoxy-carbonyl-β-D-glucopyranoside, or a pharmaceutically acceptable salt thereof.